Title : ABCG2- and ABCB1 Inhibition Using Supratherapeutic Doses of Erlotinib: Clinical Implications in the Treatment of Central Nervous System Metastases.

Pub. Date : 2020 Feb

PMID : 31586007






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ABCG2- and ABCB1 inhibition using supratherapeutic doses of erlotinib: clinical implications in the treatment of CNS metastases. erlotinib ATP binding cassette subfamily B member 1 Homo sapiens